U.S. federal trademark · Serial No. 76632762
Licensing of intellectual property
Pharmaceuticals, namely, agents to treat cancer, autoimmunity, chronic viral infections, and other diseases characterized by abnormal cellular proliferation, and to improve tissue regeneration, wound healing, and transplantation; and kits primarily comprising reagents for medical use in detemining the metabolic pathway used by tumors.
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.